Angstrom AI vs a2z Radiology AI

Side-by-side comparison of AI visibility scores, market position, and capabilities

Angstrom AI

EmergingHealthcare

Medical Imaging AI

Angstrom AI is a medical imaging AI company applying computer vision to analyze radiology scans and pathology slides to assist radiologists and pathologists with diagnosis. HQ: San Francisco.

AI VisibilityBeta
Overall Score
C44
Category Rank
#2 of 3
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
49
Perplexity
43
Gemini
55

About

Angstrom AI is a medical AI company developing computer vision models for clinical imaging analysis — applying deep learning to radiology images (X-rays, CT scans, MRIs) and digital pathology slides to assist physicians in detection and diagnosis. The company's AI models are trained to identify specific findings (nodules, lesions, abnormalities) in medical images, providing radiologists and pathologists with highlighted regions of interest and preliminary analysis that supports their diagnostic workflow. AI-assisted reading reduces the time required per scan, improves consistency, and provides a quality check layer for findings that could otherwise be missed under time pressure.

Full profile

a2z Radiology AI

EmergingEnterprise AI

Medical Imaging AI

a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.

About

a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.

Full profile

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.